Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Wire Cambodia.
Press releases published on August 5, 2025
STACK Infrastructure Pilots First Use of Electrochemical Low-Carbon Cement in Data Center Construction
GlobeNewswire
·
August 5, 2025
DENVER, Aug. 05, 2025 (GLOBE NEWSWIRE) -- STACK Infrastructure (“STACK”), the digital infrastructure partner to the world’s most innovative companies and a leading global developer and operator of data centers, in collaboration with Sublime Systems (“ …
electroCore Appoints James C. Theofilos to the Board of Directors
GlobeNewswire
·
August 5, 2025
ROCKAWAY, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that James C. Theofilos has been appointed to the Board of Directors, effective August 1, …
IPG Photonics Strengthens Leadership Team with Key Appointments Across Operations, Technology, and Human Resources
GlobeNewswire
·
August 5, 2025
MARLBOROUGH, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP), the global leader in high-performance fiber lasers and laser systems, today announced five senior leadership appointments as part of its ongoing efforts to …
UroGen Announces 24-Month Duration of Response of 72.2% from the Pivotal Phase 3 ENVISION Trial of ZUSDURI, the First and Only FDA-Approved Medicine for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
GlobeNewswire
·
August 5, 2025
24-month Duration of Response (DOR) of 72.2% by Kaplan-Meier estimate was attained in patients who achieved a complete response (CR) at three months (79.6%) PRINCETON, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech …
IPG Photonics Announces Second Quarter 2025 Financial Results
GlobeNewswire
·
August 5, 2025
Demand Recovery and Strategic Initiatives Drove Revenue Above Expectations Book-to-Bill was Approximately One as Bookings Also Remained Strong MARLBOROUGH, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) today reported …
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2025 Financial Results
GlobeNewswire
·
August 5, 2025
Reported positive top-line results from SUMMIT evaluating bezuclastinib in patients with NonAdvanced Systemic Mastocytosis, achieving statistical significance across all primary and key secondary endpoints On track to share pivotal trial results from PEAK …
As Inflation Rates Increase, Workers Say Salaries Lag Behind
GlobeNewswire
·
August 5, 2025
DENVER, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Nearly two-thirds of job seekers (63 percent) believe salaries are not keeping pace with inflation, according to new data from Employ Inc. While more candidates are negotiating their pay than in years past, many …
Duos Edge AI Hosts Congressman Ronny Jackson’s Staff at Amarillo Edge Data Center
GlobeNewswire
·
August 5, 2025
JACKSONVILLE, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), through its operating subsidiary Duos Edge AI, Inc. (“Duos Edge AI”), a provider of adaptive, versatile and streamlined Edge Data …
Immutep Receives Positive Feedback from FDA on Late-Stage Clinical Development of Eftilagimod Alfa in Head and Neck Cancer with CPS <1
GlobeNewswire
·
August 5, 2025
SYDNEY, AUSTRALIA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces it has received positive and …
Xsolis Announces New AI-Powered Workflow Solution, Dragonfly Navigate, to Reduce Length of Stay and Improve Efficiencies in Discharge Planning and Capacity Management
GlobeNewswire
·
August 5, 2025
FRANKLIN, Tenn., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Xsolis, an AI-driven technology company that reduces administrative waste by enabling collaboration between healthcare providers and payers, today announced the launch of Dragonfly Navigate, a discharge …
Cocrystal Pharma Presents Phase 1 Results for Pan-Viral Inhibitor CDI-988 at Department of Defense Medical Conference
GlobeNewswire
·
August 5, 2025
All CDI-988 doses, ranging from 100 mg to 1200 mg, in the Phase 1 study were well tolerated Company expects to initiate Phase 1b study with CDI-988 in norovirus-infected healthy subjects later this year Lack of approved norovirus treatments or vaccines …
BIO-key, Provider of Identity and Access Management Solutions with Enhanced Biometrics, Hosts Q2 Investor Call Wed. Aug. 13th at 10am ET
GlobeNewswire
·
August 5, 2025
HOLMDEL, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management solutions featuring passwordless, phoneless, and tokenless Identity-Bound Biometric …
ModelOp Announces Strategic Partnership with Angularis.ai to Deliver Complete Enterprise AI Governance-as-a-Service Solution
GlobeNewswire
·
August 5, 2025
CHICAGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Following its groundbreaking Agentic AI governance solution launch, ModelOp, the leader in AI lifecycle automation and governance software, today announced a strategic partnership with Angularis.ai, a hands-on AI …
Rackspace Technology Launches Cloud Management Platform with New Capabilities for Hybrid Environments
GlobeNewswire
·
August 5, 2025
SAN ANTONIO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), a leading end-to-end hybrid cloud and AI solutions company, today announced the launch of the Rackspace Cloud Management Platform, which includes next-gen upgrades to the …
Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)
GlobeNewswire
·
August 5, 2025
TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today …
Nuvectis Pharma, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
August 5, 2025
NXP900 becomes the lead drug candidate after successfully completing the Phase 1a dose escalation study in patients with advanced solid tumors and a drug-drug interaction study in healthy volunteers; initiation of Phase 1b program is imminent Strengthened …
Humanoid Global Welcomes Dr. Ahad Armin to its Technical Advisory Committee
GlobeNewswire
·
August 5, 2025
Vancouver, BC, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCPK:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering …
Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 5, 2025
- Full data for Phase 1/2 dose expansion cohort expected by year-end 2025 - - Cash runway into the second quarter of 2026 - BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company …
Altimmune to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025
GlobeNewswire
·
August 5, 2025
GAITHERSBURG, Md., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that it will report its second quarter 2025 financial results on Tuesday, August 12, 2025. Altimmune …
Flare Therapeutics Announces Initiation of Phase 1B Study of FX-909 for Treatment of Metastatic Urothelial Cancer
GlobeNewswire
·
August 5, 2025
CAMBRIDGE, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced that it …